| Kimberly Ann Tozer, CRNA | |
|
501 Gopher Dr, Tomah, WI 54660 | |
| (608) 372-2181 | |
| Not Available |
| Full Name | Kimberly Ann Tozer |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 10 Years |
| Location | 501 Gopher Dr, Tomah, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104214907 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 758358 (California) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 8948-33 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Michaels Hospital | Stevens point, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Stevens Point Hospital And Clinics, Inc. | 1850358938 | 115 |
| Mile Bluff Medical Center Inc | 8527971399 | 77 |
News Archive
It could be decades before science can accurately measure the body's systems to determine which foods, in what quantities and combinations, will best combat against disease and illness, experts say.
"Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies"
Pharma major, Lupin Ltd announced today that it has received official communication from the US FDA on the satisfactory resolution of the Warning Letter issued earlier to its Mandideep site. The company had received a Warning letter for its Mandideep site in May 2009. In the ensuing seven months, the company made significant enhancements and took appropriate corrective actions.
The Washington Post reports on hospitals' efforts to reduce readmission rates, while KHN details how some states are working on insurance coverage quality ratings before the federal health law requires them to do so in 2016.
Mayo Clinic investigators have found that the medication mycophenolate mofetil is effective for managing symptoms of systemic lupus erythematosus (SLE), the most common type of lupus, for patients whose SLE does not affect the kidneys.
› Verified 4 days ago
| Entity Name | Mile Bluff Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922145077 PECOS PAC ID: 8527971399 Enrollment ID: O20031107000323 |
News Archive
It could be decades before science can accurately measure the body's systems to determine which foods, in what quantities and combinations, will best combat against disease and illness, experts say.
"Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies"
Pharma major, Lupin Ltd announced today that it has received official communication from the US FDA on the satisfactory resolution of the Warning Letter issued earlier to its Mandideep site. The company had received a Warning letter for its Mandideep site in May 2009. In the ensuing seven months, the company made significant enhancements and took appropriate corrective actions.
The Washington Post reports on hospitals' efforts to reduce readmission rates, while KHN details how some states are working on insurance coverage quality ratings before the federal health law requires them to do so in 2016.
Mayo Clinic investigators have found that the medication mycophenolate mofetil is effective for managing symptoms of systemic lupus erythematosus (SLE), the most common type of lupus, for patients whose SLE does not affect the kidneys.
› Verified 4 days ago
| Entity Name | Tomah Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992970453 PECOS PAC ID: 6901897016 Enrollment ID: O20040519000123 |
News Archive
It could be decades before science can accurately measure the body's systems to determine which foods, in what quantities and combinations, will best combat against disease and illness, experts say.
"Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies"
Pharma major, Lupin Ltd announced today that it has received official communication from the US FDA on the satisfactory resolution of the Warning Letter issued earlier to its Mandideep site. The company had received a Warning letter for its Mandideep site in May 2009. In the ensuing seven months, the company made significant enhancements and took appropriate corrective actions.
The Washington Post reports on hospitals' efforts to reduce readmission rates, while KHN details how some states are working on insurance coverage quality ratings before the federal health law requires them to do so in 2016.
Mayo Clinic investigators have found that the medication mycophenolate mofetil is effective for managing symptoms of systemic lupus erythematosus (SLE), the most common type of lupus, for patients whose SLE does not affect the kidneys.
› Verified 4 days ago
| Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
It could be decades before science can accurately measure the body's systems to determine which foods, in what quantities and combinations, will best combat against disease and illness, experts say.
"Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies"
Pharma major, Lupin Ltd announced today that it has received official communication from the US FDA on the satisfactory resolution of the Warning Letter issued earlier to its Mandideep site. The company had received a Warning letter for its Mandideep site in May 2009. In the ensuing seven months, the company made significant enhancements and took appropriate corrective actions.
The Washington Post reports on hospitals' efforts to reduce readmission rates, while KHN details how some states are working on insurance coverage quality ratings before the federal health law requires them to do so in 2016.
Mayo Clinic investigators have found that the medication mycophenolate mofetil is effective for managing symptoms of systemic lupus erythematosus (SLE), the most common type of lupus, for patients whose SLE does not affect the kidneys.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Ann Tozer, CRNA 501 Gopher Dr, Tomah, WI 54660-4513 Ph: (608) 372-2181 | Kimberly Ann Tozer, CRNA 501 Gopher Dr, Tomah, WI 54660 Ph: (608) 372-2181 |
News Archive
It could be decades before science can accurately measure the body's systems to determine which foods, in what quantities and combinations, will best combat against disease and illness, experts say.
"Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies"
Pharma major, Lupin Ltd announced today that it has received official communication from the US FDA on the satisfactory resolution of the Warning Letter issued earlier to its Mandideep site. The company had received a Warning letter for its Mandideep site in May 2009. In the ensuing seven months, the company made significant enhancements and took appropriate corrective actions.
The Washington Post reports on hospitals' efforts to reduce readmission rates, while KHN details how some states are working on insurance coverage quality ratings before the federal health law requires them to do so in 2016.
Mayo Clinic investigators have found that the medication mycophenolate mofetil is effective for managing symptoms of systemic lupus erythematosus (SLE), the most common type of lupus, for patients whose SLE does not affect the kidneys.
› Verified 4 days ago
Cole B Dolan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 501 Gopher Dr, Tomah, WI 54660 Phone: 608-372-2181 | |
Mr. David Roy Demask, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 501 Gopher Dr, Tomah, WI 54660 Phone: 608-372-2181 | |
Mr. Jeffrey Lee Jerde, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 501 Gopher Dr, Tomah, WI 54660 Phone: 608-372-2181 | |
Daniel R Langan Ii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 501 Gopher Dr, Tomah, WI 54660 Phone: 608-697-4277 | |
Andrew Jones, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 501 Gopher Dr, Tomah, WI 54660 Phone: 608-372-2181 |